Innate Pharma
IPHA
#8322
Rank
A$0.27 B
Marketcap
$3.27
Share price
-5.09%
Change (1 day)
-14.34%
Change (1 year)

Innate Pharma (IPHA) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : A$0.23 Billion

According to Innate Pharma 's latest financial reports the company's total liabilities are A$0.23 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Innate Pharma - Total liabilities on balance sheet (from 2009 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.24 B-3.09%
2021-12-31A$0.25 B3.21%
2020-12-31A$0.24 B-17.69%
2019-12-31A$0.29 B-36.18%
2018-12-31A$0.46 B77.48%
2017-12-31A$0.25 B-8.88%
2016-12-31A$0.28 B-18.77%
2015-12-31A$0.35 B1370.51%
2014-12-31A$23.87 M-1.13%
2013-12-31A$24.14 M-23.91%
2012-12-31A$31.73 M-25.17%
2011-12-31A$42.4 M123.45%
2010-12-31A$18.97 M-30.4%
2009-12-31A$27.26 M-29.51%
2008-12-31A$38.68 M70.97%
2007-12-31A$22.62 M4.89%
2006-12-31A$21.56 M183.4%
2005-12-31A$7.61 M